Pascal Lapierre
Biographic Data
| ID | 9993931 |
|---|---|
| NAME | Pascal Lapierre |
| GIVEN NAMES | Pascal |
| FAMILY NAME | Lapierre |
| SIGNATURE | LAPIERRE P |
| AFFILIATIONS | New York State Department of Health |
| ORCID | 0000-0003-1238-0955 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Whole genome sequencing of neurotoxin-producing Clostridium species in New York state to bolster epidemiological investigations and reveal patterns of diversity and distribution
Clostridia that produce neurotoxins are highly relevant organisms to public health. While cases of botulism [caused by C. botulinum and other organisms that produce botulinum neurotoxin (BoNT)] are rare, the severity of this disease necessitates robust epidemiologic surveillance to promptly identify and mitigate outbreaks. Next generation sequencing (NGS) can provide additional support to these investigations through single nucleotide polymorphis…
Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing
Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens are not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) drug susceptibility testing on slow growing bacteria like MTBC requires many weeks to months to complete, whereas sequencing-based approaches can predict drug resistance (DR) with reduced turnaround time. We sought to devel…
No prominent works on this page.
Direct detection of drug-resistant Mycobacterium tuberculosis using targeted next generation sequencing
Mycobacterium tuberculosis complex (MTBC) infections are treated with combinations of antibiotics; however, these regimens are not as efficacious against multidrug and extensively drug resistant MTBC. Phenotypic (growth-based) drug susceptibility testing on slow growing bacteria like MTBC requires many weeks to months to complete, whereas sequencing-based approaches can predict drug resistance (DR) with reduced turnaround time. We sought to devel…
Whole genome sequencing of neurotoxin-producing Clostridium species in New York state to bolster epidemiological investigations and reveal patterns of diversity and distribution
Clostridia that produce neurotoxins are highly relevant organisms to public health. While cases of botulism [caused by C. botulinum and other organisms that produce botulinum neurotoxin (BoNT)] are rare, the severity of this disease necessitates robust epidemiologic surveillance to promptly identify and mitigate outbreaks. Next generation sequencing (NGS) can provide additional support to these investigations through single nucleotide polymorphis…
Polymerase chain reaction (2 works) · Amplicon (1 work) · Antibiotic Resistance in Bacteria (1 work) · Biodefense (1 work) · Biology (1 work) · Botulinum Toxin and Related Neurological Disorders (1 work) · Botulism (1 work) · Clostridium botulinum (1 work) · Clostridium difficile and Clostridium perfringens research (1 work) · Diphtheria, Corynebacterium, and Tetanus (1 work)